Hyperlactatemia and Antiretroviral Therapy: The Swiss HIV Cohort Study
Authors:
Open Access
- 1 December 2001
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 33 (11) , 1931-1937
Abstract
The prevalence, clinical presentation, and risk factors for hyperlactatemia among patients receiving antiretroviral therapy was determined during a 1Keywords
This publication has 25 references indexed in Scilit:
- Steatosis–lactic acidosis syndrome associated with stavudine and lamivudine therapyAIDS, 2000
- A syndrome of lipoatrophy, lactic acidaemia and liver dysfunction associated with HIV nucleoside analogue therapy: contribution to protease inhibitor-related lipodystrophy syndromeAIDS, 2000
- Lactic Acidosis Associated with Stavudine Administration: A Report of Five CasesClinical Infectious Diseases, 2000
- Hepatic steatosis and lactic acidosis associated with stavudine treatment in an HIV patient: a case reportAIDS, 1997
- Massive Hepatic Steatosis and Lactic Acidosis in a Patient with AIDS Who Was Receiving ZidovudineClinical Infectious Diseases, 1995
- Fulminant hepatitis with severe lactate acidosis in HIV‐infected patients on didanosine therapyJournal of Internal Medicine, 1994
- Hepatomegaly with severe steatosis in HIV-seropositive patientsAIDS, 1993
- Fulminant Hepatic Failure Associated with 2′,3′-Dideoxyinosine (ddI)Annals of Internal Medicine, 1991
- Depletion of muscle mitochondrial DNA in AIDS patients with zidovudine-induced myopathyThe Lancet, 1991
- Mitochondrial Myopathy Caused by Long-Term Zidovudine TherapyNew England Journal of Medicine, 1990